Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A cheap blood test could sharpen ICU risk prediction

NCT ID NCT07775911

Knowledge-focused Sponsor: Sohag University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study asks whether a simple ratio from a standard blood test, called RDW:MCHC, can help predict which critically ill patients are most likely to die in the intensive care unit (ICU). Researchers will follow 200 adult ICU patients and compare this ratio with the widely used SOFA score, which measures organ failure. The goal is to see if adding RDW:MCHC improves the accuracy of risk assessment, potentially helping doctors make better treatment decisions and use ICU resources more wisely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the ratio proves useful, it could give doctors a simple, inexpensive tool to better identify ICU patients at highest risk, helping guide care and resource use.
What could go wrong
This is an observational study, so it can only show links, not cause and effect. The ratio may not add meaningful accuracy beyond existing scores, and results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

200 people

The number who actually took part.

Started

Jul 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All consecutive adult patients (≥18 years) admitted to the Intensive Care Unit (ICU) at Sohag University Hospital, a tertiary care referral hospital, who meet the eligibility criteria. The study population includes both obstetric (pregnant and postpartum) and non-obstetric (non-pregnant) critically ill patients. Patients with documented hematological malignancies or recent blood transfusion (within 7 days prior to ICU admission) are excluded.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • ICU stay of at least 24 hours duration * Available complete blood count (CBC) parameters at the time * pregnant women at any gestational age and postpartum women (up to 6 weeks following delivery) are eligible * Adult patients (≥18 years) Exclusion Criteria: * • Documented hematological malignancies (including leukemia, lymphoma, and myelodysplastic syndromes) * Recent blood transfusion (within 7 days prior to ICU admission)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness

Contacts and locations

Locations

  • Sohag university .faculty of medicine .internal medicine department

    Sohag, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.